Lamotrigine (Lamictal IR) for the treatment of bipolar disorder
- PMID: 23140205
- DOI: 10.1517/14656566.2012.741590
Lamotrigine (Lamictal IR) for the treatment of bipolar disorder
Abstract
Introduction: Over the past decade the use of lamotrigine in bipolar disorder has increased. However, the evidence base suggests a more limited role for lamotrigine as part of an overall treatment regimen in bipolar disorder.
Areas covered: We reviewed publications of randomized clinical trials of lamotrigine, emphasizing studies in bipolar disorder. The low burden of adverse effects with lamotrigine has been confirmed in these studies. Its lack of benefit in acute mania is established. Despite modest benefits for a subset of depressive episodes in bipolar disorder, it was not superior to placebo in well-designed studies. As monotherapy, in randomized, blinded trials in rapid cycling bipolar disorder it was not superior to placebo. Its role in maintenance treatment is relatively well established as one component of combination therapy, with evidence for benefits when combined with lithium or valproate. Combination regimens including lamotrigine appear to be superior to monotherapy. Monotherapy utilization of lamotrigine for maintenance treatment is not supported by these studies.
Expert opinion: Lamotrigine has benefits in bipolar disorder management principally as a component of combination treatment which includes a mood stabilizer. The utility of lamotrigine in acute bipolar depression and major depressive disorder is modest.
Similar articles
-
Lamotrigine: a review of its use in bipolar disorder.Drugs. 2003;63(19):2029-50. doi: 10.2165/00003495-200363190-00009. Drugs. 2003. PMID: 12962521 Review.
-
Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.J Clin Psychiatry. 2009 Sep;70(9):1273-80. doi: 10.4088/JCP.08m04381. Epub 2009 Aug 11. J Clin Psychiatry. 2009. PMID: 19689918
-
Lamotrigine for bipolar disorder: translating research into clinical practice.Expert Rev Neurother. 2004 May;4(3):363-70. doi: 10.1586/14737175.4.3.363. Expert Rev Neurother. 2004. PMID: 15853534 Review.
-
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.Arch Gen Psychiatry. 2003 Apr;60(4):392-400. doi: 10.1001/archpsyc.60.4.392. Arch Gen Psychiatry. 2003. PMID: 12695317 Clinical Trial.
-
Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).Bipolar Disord. 2010 Aug;12(5):483-93. doi: 10.1111/j.1399-5618.2010.00836.x. Bipolar Disord. 2010. PMID: 20712749 Clinical Trial.
Cited by
-
Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer.Front Pharmacol. 2015 Oct 23;6:242. doi: 10.3389/fphar.2015.00242. eCollection 2015. Front Pharmacol. 2015. PMID: 26557090 Free PMC article. Review.
-
Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis.Psychopharmacol Bull. 2020 Sep 14;50(4):118-136. Psychopharmacol Bull. 2020. PMID: 33012875 Free PMC article.
-
Lamotrigine in the maintenance treatment of bipolar disorder.Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD013575. doi: 10.1002/14651858.CD013575.pub2. Cochrane Database Syst Rev. 2021. PMID: 34523118 Free PMC article. Review.
-
New avenues for anti-epileptic drug discovery and development.Nat Rev Drug Discov. 2013 Oct;12(10):757-76. doi: 10.1038/nrd4126. Epub 2013 Sep 20. Nat Rev Drug Discov. 2013. PMID: 24052047 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
